Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
11.80
-0.34 (-2.84%)
Nov 10, 2025, 11:36 AM EST - Market open
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $24.15 million as of November 10, 2025. Its market cap has increased by 59.49% in one year.
Market Cap
24.15M
Enterprise Value
19.29M
1-Year Change
59.49%
Ranking
Category
Stock Price
$11.80
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $24.15M, a decrease of -58.48%. That is a compound annual growth rate of -26.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 24.86M | -3.75% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |